These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 20008946

  • 1. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P, Ward HE, Tremblay P, Laberge L, Hébert C, Bergeron R.
    Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
    [Abstract] [Full Text] [Related]

  • 2. Combining antidepressant medications: a good idea?
    Rush AJ.
    Am J Psychiatry; 2010 Mar; 167(3):241-3. PubMed ID: 20194484
    [No Abstract] [Full Text] [Related]

  • 3. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ.
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [Abstract] [Full Text] [Related]

  • 4. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA, OPERATION Study Team.
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [Abstract] [Full Text] [Related]

  • 5. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC, Haley CL, Wisniewski SR, Fava M, Nierenberg AA, Warden D, Morris DW, Kurian BT, Trivedi MH, Rush AJ, CO-MED Study Team.
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [Abstract] [Full Text] [Related]

  • 6. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
    Amini H, Aghayan S, Jalili SA, Akhondzadeh S, Yahyazadeh O, Pakravan-Nejad M.
    J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165
    [Abstract] [Full Text] [Related]

  • 7. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
    Zisook S, Lesser IM, Lebowitz B, Rush AJ, Kallenberg G, Wisniewski SR, Nierenberg AA, Fava M, Luther JF, Morris DW, Trivedi MH.
    J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
    [Abstract] [Full Text] [Related]

  • 8. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
    Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S, Mirtazapine-Venlafaxine Study Group.
    J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
    [Abstract] [Full Text] [Related]

  • 9. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
    Marcus RN, McQuade RD, Carson WH, Hennicken D, Fava M, Simon JS, Trivedi MH, Thase ME, Berman RM.
    J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
    [Abstract] [Full Text] [Related]

  • 10. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K, Chrzanowski W, Schmitz M, Savela A, Milanova V, Gee M, Krishen A, Millen L, Leary MO, Modell J.
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [Abstract] [Full Text] [Related]

  • 11. Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
    Warden D, Trivedi MH, Carmody T, Toups M, Zisook S, Lesser I, Myers A, Kurian KR, Morris D, Rush AJ.
    J Psychiatr Pract; 2014 Mar; 20(2):118-32. PubMed ID: 24638046
    [Abstract] [Full Text] [Related]

  • 12. Sexual functioning in patients with recurrent major depressive disorder enrolled in the PREVENT study.
    Gelenberg AJ, Dunner DL, Rothschild AJ, Pedersen R, Dorries KM, Ninan PT.
    J Nerv Ment Dis; 2013 Apr; 201(4):266-73. PubMed ID: 23538970
    [Abstract] [Full Text] [Related]

  • 13. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
    Trivedi MH, Thase ME, Osuntokun O, Henley DB, Case M, Watson SB, Campbell GM, Corya SA.
    J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
    [Abstract] [Full Text] [Related]

  • 14. Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
    Benkert O, Szegedi A, Philipp M, Kohnen R, Heinrich C, Heukels A, van der Vegte-Senden M, Baker RA, Simmons JH, Schutte AJ.
    J Clin Psychopharmacol; 2006 Feb; 26(1):75-8. PubMed ID: 16415711
    [Abstract] [Full Text] [Related]

  • 15. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G.
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
    [Abstract] [Full Text] [Related]

  • 16. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP, Gardner EA, Johnston JA, Batey SR, Khayrallah MA, Ascher JA, Lineberry CG.
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [Abstract] [Full Text] [Related]

  • 17. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR, Meoni P, Haudiquet V, Cantillon M, Hackett D.
    Depress Anxiety; 2002 Aug; 16(1):4-13. PubMed ID: 12203668
    [Abstract] [Full Text] [Related]

  • 18. Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.
    Shelton C, Entsuah R, Padmanabhan SK, Vinall PE.
    Int Clin Psychopharmacol; 2005 Jul; 20(4):233-8. PubMed ID: 15933485
    [Abstract] [Full Text] [Related]

  • 19. Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.
    Chekroud AM, Gueorguieva R, Krumholz HM, Trivedi MH, Krystal JH, McCarthy G.
    JAMA Psychiatry; 2017 Apr 01; 74(4):370-378. PubMed ID: 28241180
    [Abstract] [Full Text] [Related]

  • 20. Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features.
    Sheehan DV, Nemeroff CB, Thase ME, Entsuah R, EPIC 016 Study Group.
    Int Clin Psychopharmacol; 2009 Mar 01; 24(2):61-86. PubMed ID: 19238088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.